Asya Varshavsky - Concepedia

Author

Asya Varshavsky

Technion – Israel Institute of Technology

Also Known As

A VARSHAVSKY, Asya Varshavsky

Publications

730

Citations

H-Index

Concepts

All Affiliations

Technion – Israel Institute of Technology Rappaport Family Institute for Research in the Medical Sciences Fox Chase Cancer Center

About

Asya Varshavsky is an author at Technion – Israel Institute of Technology specializing in tumor microenvironment, medicine, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	394
2	Cell Biology	2	2	355
3	Health Sciences	1	1	222
4	Immunology	1	1	39
5	Pathology	1	1	39

Asya Varshavsky

Publications

679

Citations

H-Index

Page 1

	Year	Citations
Semaphorin-3A and Semaphorin-3F Work Together to Repel Endothelial Cells and to Inhibit Their Survival by Induction of Apoptosis Noga Guttmann‐Raviv, Niva Shraga‐Heled, Asya Varshavsky, Journal of Biological Chemistry Endothelial CellsApoptosisCell DeathCell GrowthOxidative Stress	2007	222
Successful Inhibition of Tumor Development by Specific Class-3 Semaphorins Is Associated with Expression of Appropriate Semaphorin Receptors by Tumor Cells Boaz Kigel, Asya Varshavsky, Ofra Kessler, PLoS ONE Family MembersCancer BiologyTumor BiologyClass-3 SemaphorinsTumor Angiogenesis	2008	133
Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling Boaz Kigel, Noa Rabinowicz, Asya Varshavsky, Blood	2011	131
Semaphorin-3B Is an Angiogenesis Inhibitor That Is Inactivated by Furin-Like Pro-Protein Convertases Asya Varshavsky, Ofra Kessler, Sivan Abramovitch, Cancer Research	2008	125
Dual Checkpoint Inhibition with Ipilimumab plus Nivolumab After Progression on Sequential PD-1/PDL-1 Inhibitors Pembrolizumab and Atezolizumab in a Patient with Lynch Syndrome, Metastatic Colon, and Localized Urothelial Cancer Arthur Winer, Pooja Ghatalia, Nicole Bubes, The Oncologist ImmunologyPathologyPharmacotherapyImmune Checkpoint BlockadeImmunotherapy	2019	39
Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic Pooja Ghatalia, Chad H. Smith, Arthur Winer, Frontiers in Oncology	2019	15
Lymphocyte Exhaustion in AML Patients and Impacts of HMA/Venetoclax or Intensive Chemotherapy on Their Biology Dmitry Zhigarev, Asya Varshavsky, Alexander W. Macfarlane, Cancers	2022	14

Page 1